Markstein, R.
42  results:
Search for persons X
?
1

Effects of Antiglaucoma Drugs GLC756, a Novel Dopamine D2 A..:

Laengle, U.W. ; Markstein, R. ; Schneider, V..
European Journal of Ophthalmology.  16 (2006)  3 - p. 401-406 , 2006
 
?
2

Effects of Latanoprost and GLC756, a Novel Dopamine D2 Agon..:

Laengle, U.W. ; Markstein, R. ; Pralet, D...
European Journal of Ophthalmology.  16 (2006)  1 - p. 67-72 , 2006
 
?
3

Effects of anti-glaucoma drugs timolol and GLC756, a novel ..:

Laengle, U.W. ; Court, M. ; Markstein, R....
Experimental and Toxicologic Pathology.  57 (2005)  2 - p. 127-134 , 2005
 
?
6

Dopamine D4-like receptors in untreated schizophrenic patie..:

Klimke, A. ; Boy, C. ; Eickhoff, M....
European Neuropsychopharmacology.  8 (1998)  - p. S235 , 1998
 
?
 
?
8

Effects of dopamine D-1 and D-2 receptors on intraocular pr..:

Pr�nte, C. ; Nuttli, I. ; Markstein, R..
Journal of Neural Transmission.  104 (1997)  2-3 - p. 111-123 , 1997
 
?
9

Density and distribution of dopamine D4 receptors in primat..:

Klimke, A. ; Boy, C. ; Herzog, H....
Biological Psychiatry.  42 (1997)  1 - p. 164S-165S , 1997
 
?
10

SDZ PSD 958, a novel D1 receptor antagonist with potential ..:

Markstein, R. ; Gull, P. ; R�deberg, C....
Journal of Neural Transmission.  103 (1996)  3 - p. 261-276 , 1996
 
?
11

SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative ..:

Markstein, R. ; Gull, P. ; R�deberg, C....
Journal of Neural Transmission.  103 (1996)  1-2 - p. 17-30 , 1996
 
?
 
?
13

Structure activity relationship and therapeutic uses of dop..:

Markstein, R. ; Seiler, M.P. ; Jaton, A..
Neurochemistry International.  20 (1992)  - p. 211-214 , 1992
 
?
14

Somatostatin inhibits the activity of adenylate cyclase in ..:

Koper, J W ; Markstein, R ; Kohler, C...
The Journal of Clinical Endocrinology & Metabolism.  74 (1992)  3 - p. 543-547 , 1992
 
?
15

Dopamine agonists potentiate antiakinetic effects of compet..:

Kannari, K. ; Markstein, R.
Journal of Neural Transmission.  84 (1991)  3 - p. 211-220 , 1991
 
1-15